New Clinical Recommendations For COVID-19 In Severe Asthma emphasise the importance of maintaining usual asthma therapy including monoclonal antibodies and oral corticosteroids when indicated. The consensus document, from the Centre of Excellence in Severe Asthma in Newcastle, said there was no evidence to suggest that asthma or MAB therapy constituted an increased risk for acquiring ...
Consensus statement on severe asthma amid COVID-19
By Mardi Chapman
18 May 2020